Alector (ALEC) Asset Writedowns and Impairment (2024 - 2025)
Alector's (ALEC) quarterly Asset Writedowns and Impairment came in at $1.7 million in Q4 2025, down 20.68% on a QoQ basis from $2.2 million in Q3 2024.
Alector (ALEC) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
Alector (ALEC) has 2 years of Asset Writedowns and Impairment data on file, last reported at $1.7 million in Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $4.0 million, a 79.32% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 31.52% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at $1.7 million, down from $2.2 million in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for ALEC reached as high as $2.2 million in Q3 2024 and fell as low as $1.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.75 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.21 Mn |